SCA
MNTA

SAC Capital Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

SAC Capital Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-3,029,124
Closed -$35.3M – 1222
2014
Q1 		$35.3M Buy
+3,029,124
New +$51.3M 0.18% 151
2013
Q4 		– Sell
-28,621
Closed -$412K – 2060
2013
Q3 		$412K Buy
+28,621
New +$438K ﹤0.01% 1236

Other funds holding MNTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SAC Capital Advisors's MNTA Position: Q2 2014 in Review

SAC Capital Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2014, closing a stake of 3,029,124 shares — an estimated $35.3M sold.

SAC Capital Advisors first reported a position in MNTA in Q3 2013 and held it in 2 quarters. The position peaked at $35.3M in Q1 2014. 148 funds tracked by Wall St. Rank hold MNTA as of Q2 2014.

  • SAC Capital Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 3,029,124 Momenta Pharmaceuticals, Inc. shares in Q2 2014, an estimated $35.3M.
  • SAC Capital Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2013 and held it in 2 quarters.
  • SAC Capital Advisors's Momenta Pharmaceuticals, Inc. position peaked at $35.3M in Q1 2014.
  • 148 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.